By Professor Nada Hamad

Preprints

Hamad N; Barge L; Tran S; Kennedy G; Ritchie D; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey R; Larsen S; Butler A; Bardy P; Greenwood M; Durrant S; Curley C; Stewart C; Tam C; Balendran S; Ciaccio PD; Patil S; Han M-H, 2024, Outcomes of Allogeneic Haematopoietic Transplant for Chronic Lymphocytic Leukaemia in the Modern Era, http://dx.doi.org/10.21203/rs.3.rs-4050578/v1

Body A; Donoghoe M; Lal L; Wakefield C; Ahern ES; Anazodo A; Fuentes Bolanos NA; Padhye B; Downie P; Opat S; Hamad N; Leahy MF; Milch V; Segelov E, 2024, Vaccine beliefs, adverse effects, and quality of life in patients with cancer undergoing routine COVID-19 vaccination, http://dx.doi.org/10.1101/2024.06.02.24308345

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358

Wood E; Anderson M-A; Berkahn L; Cheah C; Dickinson M; Gandhi M; Giri P; Hawkes E; Johnston A; Keane C; McQuilten Z; Mulligan S; Talaulikar D; Opat S; Trotman J; Williams J; Armytage T; Barraclough A; Carradice D; Chong G; Cochrane T; Hamad N; Ku M; Lee D; Morgan S; Mutsando H; Narayana M; Prince M; Ratnasingam S; Wight J; Badoux X; Cull G; Kuss B; Marlton P; Tam C; Casan J; Cushion T; Tedjaseputra A; Birch S; Brown C; Ellis D; Harvey Y; Hitchins S; Jain S; Jessup P; Juneja S; Kearney D; Kumar B; Lade S; Lee K; Leslie C; Long E; Morey A; Nath L; Norris D; Parker A; Parry J; Chen FP-Y; Chung E; Morison J; Rowsell L; George GS; Thu C; Waters N; Wellard C; Zheng M, 2022, Improving outcomes for patients with lymphoma: Design and development of the Australian Lymphoma and Related Diseases Registry, http://dx.doi.org/10.21203/rs.3.rs-1370973/v1

Bain N; Nguyen M; Grech L; Day D; McCartney A; Webber K; Kwok A; Harris S; Chau H; Chan B; Nott L; Hamad N; Tognela A; Underhill C; Loe BS; Freeman D; Segelov E, 2022, COVID-19 vaccine hesitancy in Australian patients with solid organ cancers, http://dx.doi.org/10.1101/2022.07.08.22277398

Day D; Grech L; Nguyen M; Bain N; Kwok A; Harris S; Chau H; Chan B; Blennerhassett R; Nott L; Hamad N; Tognela A; Hoffman D; McCartney A; Webber K; Wong J; Underhill C; Sillars B; Winkel A; Savage M; Loe BS; Freeman D; Segelov E, 2022, Serious underlying medical conditions and COVID-19 vaccine hesitancy, http://dx.doi.org/10.1101/2022.04.06.22273080

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill BT; Jaeger U; Sancho JM; Schuster M; Thieblemont C; de la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos T; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van den Neste E; Canales M, Selinexor in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (SADAL): A Single-Arm Multinational Phase 2 Trial, http://dx.doi.org/10.2139/ssrn.3526327

Back to profile page